Skip to content
DataLookout
Menu

dOccLSNCT05953038

LSD Occupancy of the Serotonin 2A Receptor in the Human Brain

StatusRecruiting
PhaseEarly Phase 1
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Enrollment reopened Show 5 more changesShow less
    • Lead sponsor: Rigshospitalet, Denmark to Copenhagen University Hospital, Rigshospitalet
    • Eligibility criteria shortened, about 1 word
    • Secondary endpoints: details revised at 4 of 5 entries
    • Study description revised
    • Site details revised
  2. Minor Primary completion date: Dec 18, 2027 to Dec 2027v4
  3. Notable Primary completion date: Jun 2024 to Dec 18, 2027
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Dec 2024 to Dec 31, 2027
    • Site details revised
    v3
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 1, 2023 to Nov 8, 2023
    • Site details revised
    v2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Plasma LSD - serotonin 2A receptor (5-HT2AR) occupancy relation
Timeframe: Within 24 hours following drug administration

Secondary (5)

Subjective drug intensity - 5-HT2AR occupancy relation
fMRI network disintegration - 5-HT2AR occupancy relation
fMRI brain entropy - 5-HT2AR occupancy relation
Cerebral perfusion - 5-HT2AR occupancy relation
Administered LSD dose - 5-HT2AR occupancy relation

Arms and interventions

LSD dose-ranging groupExperimental

All participants will receive between 25 and 200 micrograms of lysergic acid diethylamide equivalent as freebase, single blinded with respect to dose. Simultaneous PET/MR imaging will be performed during acute drug effects.

Drugs: Lysergic Acid Diethylamide Tartrate

Sites

1 site in 1 country

  • Neurobiology Research Unit, RigshospitaletCopenhagen, Denmark